Enhancing treatment with pliaglis®
Pliaglis®, a new FDA approved self-occluding, long-lasting topical anaesthetic, provides an enhanced treatment experience
Read MorePRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
